T338C Src-IN-2 blocks the activity of Src kinases, which are involved in various cellular processes such as growth, differentiation, and survival, and have been implicated in the progression of several cancers and other diseases.
Molecular Weight
327.36
Molecular Formula
C17H18FN5O
Form
Lyophilized powder
Purity
≥98%
Identity
Confirmed by NMR/HPLC/MS.
Applications
T338C Src-IN-2 is used to investigate signaling pathways in cancer by inhibiting mutant variants of Src kinase in lab studies.
CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.
